Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice.

BACKGROUND The neurodegenerative process in Alzheimer's disease, one of the most common types of dementia worldwide, mostly affects the cholinergic neurotransmitter system and, to a lesser extent, the monoaminergic one. The antioxidant acetylcholinesterase (AChE) and triple monoamine reuptake inhibitory activity of Sideritis scardica (S. scardica) and other Sideritis species has already been reported. OBJECTIVE To investigate the effects of S. scardica water extracts on the learning and memory processes, anxiety-like behavior, and locomotor activities in scopolamine (Sco)-induced dementia in mice. METHODS Male Albino IRC mice were used. The plant extract was administered for 11 consecutive days in the presence or absence of Sco (1 mg/kg, i.p). The behavioural performance of the animals was evaluated by passive avoidance, T-maze, and hole-board tests. The effects of extract on AChE activity, brain noradrenalin (NA), and serotonin (Sero) content, and antioxidant status were also monitored. RESULTS Our experimental data revealed that the S. scardica water extract caused a reduction in degree of memory impairment and anxiety-like behaviour in mice with scopolamine-induced dementia. The extract did not affect changed by the Sco AChE activity but impact reduced brain NA and Sero levels and demonstrated moderate antioxidant activity. In healthy mice we did not confirm the presence of anxiolytic-like and AChE inhibitory effects of the S. scardica water extract. The extract did not change the control Sero brain levels and reduce those of NA. CONCLUSION S. scardica water extract demonstrated memory preserving effect in mice with scopolamine-induced dementia and deserve further attention.

[1]  R. Bateman,et al.  Lecanemab in Early Alzheimer's Disease. , 2022, The New England journal of medicine.

[2]  K. E. Malterud,et al.  Immunomodulating polyphenols from Sideritis scardica , 2022, Journal of Functional Foods.

[3]  E. Mavrogonatou,et al.  Phytochemical Study and In Vitro Screening Focusing on the Anti-Aging Features of Various Plants of the Greek Flora , 2021, Antioxidants.

[4]  Ming-Hua Yang,et al.  Estimation of total flavonoid content in propolis by two complementary colometric methods , 2020, Journal of Food and Drug Analysis.

[5]  P. Chatzopoulou,et al.  NMR-Based Chemical Profiling, Isolation and Evaluation of the Cytotoxic Potential of the Diterpenoid Siderol from Cultivated Sideritis euboea Heldr. , 2020, Molecules.

[6]  M. Sulaiman,et al.  Effect of zerumbone on scopolamine-induced memory impairment and anxiety-like behaviours in rats , 2019, Alzheimer's & dementia.

[7]  H. Demirelma DETERMINATION OF THE CYTOTOXIC EFFECT ON HUMAN COLON CANCER AND PHENOLIC SUBSTANCE CONTENT OF THE ENDEMIC SPECIES SIDERITIS OZTURKII AYTAÇ & AKSOY , 2019, Applied Ecology and Environmental Research.

[8]  M. Wink,et al.  Sideritis scardica extracts inhibit aggregation and toxicity of amyloid-β in Caenorhabditis elegans used as a model for Alzheimer’s disease , 2018, PeerJ.

[9]  G. Lubec,et al.  Spatial Working Memory in Male Rats: Pre-Experience and Task Dependent Roles of Dopamine D1- and D2-Like Receptors , 2017, Front. Behav. Neurosci..

[10]  G. Lubec,et al.  Repeated application of Modafinil and Levodopa reveals a drug-independent precise timing of spatial working memory modulation , 2016, Behavioural Brain Research.

[11]  W. Dimpfel,et al.  Ex Vivo Characterization of the Action of Sideritis Extract Using Electrical Activity in the Rat Hippocampus Slice Preparation , 2016 .

[12]  K. Blennow,et al.  Alzheimer's disease , 2016, The Lancet.

[13]  M. Krohn,et al.  Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer’s β-Amyloidosis Mouse Models and Aged C57Bl/6 Mice , 2016, Journal of Alzheimer's disease : JAD.

[14]  A. Hahn,et al.  Effect of an herbal extract of Sideritis scardica and B-vitamins on cognitive performance under stress: a pilot study , 2016 .

[15]  W. Dimpfel,et al.  Psychophysiological Effects of Sideritis and Bacopa Extract and Three Combinations Thereof-A Quantitative EEG Study in Subjects Suffering from Mild Cognitive Impairment (MCI) , 2016 .

[16]  T. H. Ferreira-Vieira,et al.  Alzheimer's Disease: Targeting the Cholinergic System , 2016, Current neuropharmacology.

[17]  C. Calandra,et al.  The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia , 2015, Oxidative medicine and cellular longevity.

[18]  J. Stanoeva,et al.  Chemotaxonomic contribution to the Sideritis species dilemma on the Balkans , 2015 .

[19]  Bombi Lee,et al.  Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats , 2014, BMC Complementary and Alternative Medicine.

[20]  Nirmal Singh,et al.  Animal models of dementia and cognitive dysfunction. , 2014, Life sciences.

[21]  A. Trendafilova,et al.  Sideritis scardica Griseb., an endemic species of Balkan peninsula: traditional uses, cultivation, chemical composition, biological activity. , 2014, Journal of ethnopharmacology.

[22]  Torbjörn Persson,et al.  Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail? , 2014, Oxidative medicine and cellular longevity.

[23]  P. Kroon,et al.  Bioactive-rich Sideritis scardica tea (mountain tea) is as potent as Camellia sinensis tea at inducing cellular antioxidant defences and preventing oxidative stress. , 2013, Journal of the science of food and agriculture.

[24]  M. Stefova,et al.  Assay of urinary excretion of polyphenols after ingestion of a cup of mountain tea (Sideritis scardica) measured by HPLC-DAD-ESI-MS/MS. , 2013, Journal of agricultural and food chemistry.

[25]  V. Trajković,et al.  The Mechanisms of In Vitro Cytotoxicity of Mountain Tea, Sideritis scardica, against the C6 Glioma Cell Line , 2013, Planta Medica.

[26]  W. Dimpfel Pharmacological classification of herbal extracts by means of comparison to spectral EEG signatures induced by synthetic drugs in the freely moving rat. , 2013, Journal of ethnopharmacology.

[27]  Henry Brodaty,et al.  Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future , 2013, Alzheimer's & Dementia.

[28]  G. Stefkov,et al.  Chemical Characterization, Mineral Content and Radical Scavenging Activity of Sideritis scardica and S. raeseri from R. Macedonia and R. Albania , 2013 .

[29]  A. Cavalli,et al.  Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease , 2013, PloS one.

[30]  P. Koh Ferulic acid modulates nitric oxide synthase expression in focal cerebral ischemia , 2012, Laboratory animal research.

[31]  R. Knörle Extracts of Sideritis scardica as triple monoamine reuptake inhibitors , 2012, Journal of Neural Transmission.

[32]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[33]  A. Mahadevan,et al.  Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer’s Disease , 2012, Neurochemical Research.

[34]  P. Goverdhan,et al.  Neuroprotective Effects of Meloxicam and Selegiline in Scopolamine-Induced Cognitive Impairment and Oxidative Stress , 2012, International journal of Alzheimer's disease.

[35]  V. Trajković,et al.  Anti-inflammatory, gastroprotective, and cytotoxic effects of Sideritis scardica extracts. , 2012, Planta medica.

[36]  A. Tzakos,et al.  Phytochemical composition of “mountain tea” from Sideritis clandestina subsp. clandestina and evaluation of its behavioral and oxidant/antioxidant effects on adult mice , 2013, European Journal of Nutrition.

[37]  Julie S Snowden,et al.  The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. , 2011, Brain : a journal of neurology.

[38]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[39]  C. Constantinou,et al.  Differential antioxidant effects of consuming tea from Sideritis clandestina subsp. peloponnesiaca on cerebral regions of adult mice. , 2011, Journal of medicinal food.

[40]  W. Gattaz,et al.  Insights into Alzheimer disease pathogenesis from studies in transgenic animal models , 2011, Clinics.

[41]  F. Tomás-Barberán,et al.  Potential bioactive phenolics of Macedonian Sideritis species used for medicinal “Mountain Tea” , 2011 .

[42]  M. Stefova,et al.  Phenolic Compounds of Mountain Tea from the Balkans: LC/DAD/ESI/MSn Profile and Content , 2011, Natural product communications.

[43]  P. Denev,et al.  Solid-phase extraction of berries’ anthocyanins and evaluation of their antioxidative properties , 2010 .

[44]  M. Valko,et al.  Metals, oxidative stress and neurodegenerative disorders , 2010, Molecular and Cellular Biochemistry.

[45]  P. Denev,et al.  Evaluation of antioxidant activity of medicinal plants containing polyphenol compounds. Comparison of two extraction systems. , 2010, Acta biochimica Polonica.

[46]  Wen-Jing Chu,et al.  Functional activation of monoamine transporters by luteolin and apigenin isolated from the fruit of Perilla frutescens (L.) Britt , 2010, Neurochemistry International.

[47]  D. Perl Neuropathology of Alzheimer's disease. , 2010, The Mount Sinai journal of medicine, New York.

[48]  J. Laranjinha,et al.  Dietary polyphenols generate nitric oxide from nitrite in the stomach and induce smooth muscle relaxation. , 2009, Toxicology.

[49]  Yasuomi Ouchi,et al.  Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease , 2009, Journal of Nuclear Medicine.

[50]  H. Jacobsen,et al.  Alzheimer's disease: from pathology to therapeutic approaches. , 2009, Angewandte Chemie.

[51]  M. Boğa,et al.  Antioxidant and anticholinesterase activity evaluation of ent-kaurane diterpenoids from Sideritis arguta. , 2009, Journal of natural products.

[52]  M. Smith,et al.  Causes of oxidative stress in Alzheimer disease , 2007, Cellular and Molecular Life Sciences.

[53]  Irfan Rahman,et al.  Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method , 2006, Nature Protocols.

[54]  A. Fujii,et al.  Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats , 2006, Journal of hypertension.

[55]  Gabriele Siciliano,et al.  Mitochondrial dysfunction, oxidative stress and neurodegeneration. , 2006, Journal of Alzheimer's disease : JAD.

[56]  C. Hulette,et al.  Neuropathology of Alzheimer's disease. , 2005, Neuroimaging clinics of North America.

[57]  Atta-ur-rahman,et al.  Trends in ethnopharmacology , 2005 .

[58]  K. Başer,et al.  Antioxidant Properties and Phenolic Composition of Sideritis Species , 2004, Chemistry of Natural Compounds.

[59]  G. Reynolds,et al.  Monoamine neurotransmitters and their metabolites in brain regions in alzheimer's disease: A postmortem study , 1992, Cellular and Molecular Neurobiology.

[60]  E. Giacobini,et al.  Cholinergic function and Alzheimer's disease , 2003, International journal of geriatric psychiatry.

[61]  J. Karlawish,et al.  Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies , 2003, Annals of Internal Medicine.

[62]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[63]  Dejian Huang,et al.  Analysis of antioxidant activities of common vegetables employing oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant power (FRAP) assays: a comparative study. , 2002, Journal of agricultural and food chemistry.

[64]  Robert Lalonde,et al.  The neurobiological basis of spontaneous alternation , 2002, Neuroscience & Biobehavioral Reviews.

[65]  S. File,et al.  Factors controlling measures of anxiety and responses to novelty in the mouse , 2001, Behavioural Brain Research.

[66]  R. Prior,et al.  Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. , 2001, Journal of agricultural and food chemistry.

[67]  L. T. McGrath,et al.  Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. , 2001, QJM : monthly journal of the Association of Physicians.

[68]  C. Lyketsos,et al.  Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study. , 2000, The American journal of psychiatry.

[69]  G. Wilcock,et al.  The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.

[70]  W. D. Ehmann,et al.  Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease , 1997, Neurobiology of Aging.

[71]  J. Medina,et al.  Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. , 1995, Planta medica.

[72]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[73]  Á. Pazos,et al.  High-affinity choline uptake carrier in Alzheimer's disease: implications for the cholinergic hypothesis of dementia , 1991, Brain Research.

[74]  E. Giacobini Chapter 34 The cholinergic system in Alzheimer disease , 1990 .

[75]  G. Reynolds,et al.  Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata , 1989, Neuroscience Letters.

[76]  D. Price,et al.  The neuropathology of aminergic nuclei in Alzheimer's disease , 1988, Progress in clinical and biological research.

[77]  D. Neary,et al.  Presynaptic Serotonergic Dysfunction in Patients with Alzheimer's Disease , 1987, Journal of neurochemistry.

[78]  P. Mcgeer,et al.  Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain , 1984, Neurology.

[79]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[80]  D. Jacobowitz,et al.  Method for the rapid determination of norepinephrine, dopamine, and serotonin in the same brain region , 1978, Pharmacology Biochemistry and Behavior.

[81]  M. Jarvik,et al.  An Improved One-Trial Passive Avoidance Learning Situation , 1967, Psychological reports.

[82]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[83]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.